Journal of the American Society of Hypertension

Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey.  7. 2020

Effect of sleeve gastrectomy on hypertension.  12:e19-e25. 2018

Relation of urinary endothelin-1 to stress-induced pressure natriuresis in healthy adolescents.  12:34-41. 2018

Adherence to antihypertensive medications and associations with blood pressure among African Americans with hypertension in the Jackson Heart Study.  11:581-588.e5. 2017

Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States.  11:573-580. 2017

Involvement of vascular peroxidase 1 in angiotensin II–induced hypertrophy of H9c2 cells.  11:519-529.e1. 2017

Race and sex differences in ambulatory blood pressure measures among HIV+ adults.  11:420-427.e3. 2017

Response to letter to Editor “Lessons learned from the recent history of technologies for non-invasive estimation of aortic blood pressure using transfer functions and pulse wave analysis” by Papaioannou et al.  11:321-322. 2017

Clinic and ambulatory blood pressure in a population-based sample of African Americans: the Jackson Heart Study.  11:204-212.e5. 2017

Assessment of vascular function in low socioeconomic status preschool children: a pilot study.  11:101-109. 2017

Sleep, insomnia, and hypertension: current findings and future directions.  11:122-129. 2017

Assessment of vascular function in low socioeconomic status preschool children: A pilot study 2016

Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.  10:930-938.e9. 2016

Orthostatic changes in systolic blood pressure among SPRINT participants at baseline.  10:847-856. 2016

The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study.  10:857-864.e2. 2016

Vascular peroxidase 1 up regulation by angiotensin II attenuates nitric oxide production through increasing asymmetrical dimethylarginine in HUVECs.  10:741-751.e3. 2016

Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study.  10:625-632.e1. 2016

Hypertension and alterations in left ventricular structure and geometry in African Americans: the Jackson Heart Study.  10:550-558.e10. 2016

Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes, or a History of Stroke..  10 Suppl 1:e6-e7. 2016

HOPE-3 and SPRINT: two landmark trials with different outcomes?.  10:477-481. 2016

Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement.  10:493-499. 2016

Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: A systematic review.  10:224-234.e17. 2016

Obstructive sleep apnea and periodic limb movement disorder in a population of children with hypertension and/or nocturnal nondipping blood pressures.  10:101-107. 2016

Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension.  9:845-854. 2015

An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial.  9:769-779. 2015

Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.  9:670-679. 2015

Tribute: John H. Laragh, MD.  9:500-501. 2015

Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.  9:453-498. 2015

Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.  8:898-908. 2014

The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010.  8:891-897. 2014

Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.  8:808-819. 2014

A review of blood pressure measurement protocols among hypertension trials: Implications for "evidence-based" clinical practice.  8:670-676. 2014

Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.  8:405-413. 2014

Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk.  8:159-165. 2014

Dietary potassium: A key mediator of the cardiovascular response to dietary sodium chloride.  7:395-400. 2013

Medication adherence and stroke/TIA risk in treated hypertensives: Results from the REGARDS study.  7:363-369. 2013

Chymase mediates angiotensin-(1-12) metabolism in normal human hearts.  7:128-136. 2013

Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: A subpopulation analysis of the TRINITY study.  6:132-141. 2012

Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients.  6:66-72. 2012

ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology,.  5:259-352. 2011

Adherence and persistence with taking medication to control high blood pressure..  5:56-63. 2011

Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: Results in racial/ethnic subgroups.  5:249-258. 2011

ASH position paper: dietary approaches to lower blood pressure..  4:79-89. 2010

Combination therapy in hypertension..  4:90-98. 2010

Prevalence of hypertension by duration and age at exposure to the stroke belt.  4:32-41. 2010

Treatment of hypertension in patients with diabetes--an update..  4:62-67. 2010

Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study.  4:22-31. 2010

When and how to use self (home) and ambulatory blood pressure monitoring..  4:56-61. 2010

An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertension.  3:395-402. 2009

Diastolic dysfunction and heart failure with preserved ejection fraction: rationale for RAAS antagonist/CCB combination therapy.  3:52-68. 2009

ASH 2008: "Living the Vision".  2:54-55. 2008

Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease.  1:414-422. 2007

A Good Year.  1:369-370. 2007

A Major Paradigm Shift.  1:162-163. 2007

An Open Letter to ASH Members.  1:97-98. 2007

JASH Inaugural Issue.  1:2. 2007